Cargando…
Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the R...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783523/ https://www.ncbi.nlm.nih.gov/pubmed/33397664 http://dx.doi.org/10.1136/bmjopen-2020-040819 |
_version_ | 1783632134051725312 |
---|---|
author | Rygh, Pontus Asklund, Ina Samuelsson, Eva |
author_facet | Rygh, Pontus Asklund, Ina Samuelsson, Eva |
author_sort | Rygh, Pontus |
collection | PubMed |
description | OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the RCT. DESIGN: Prospective cohort study. PARTICIPANTS: During a 17-month period, 24 602 non-pregnant, non-postpartum women older than 18 years downloaded the app and responded anonymously to a questionnaire. Of these, 2672 (11%) responded to the 3-month follow-up. INTERVENTION: Three months’ use of the app Tät, containing information, a pelvic floor muscle training programme and lifestyle advice. MAIN OUTCOME MEASURES: Change in symptom severity (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)) and subjective improvement (Patient Global Impression of Improvement (PGI-I)). RESULTS: Of the respondents, 88% lived in Sweden and 75% (18 384/24 602) were incontinent with a mean age of 45.5 (SD 14.1) years. The UI types, based on symptoms, were SUI (53%), urgency UI (12%), mixed UI (31%) and undefined (4%). The mean ICIQ-UI SF score was 8.2 (SD 4.0) at baseline. The mean ICIQ-UI SF score reduction at follow-up was 1.31 (95% CI: 1.19 to 1.44) with a larger reduction in those with more severe incontinence at baseline (severe/very severe 3.23 (95% CI: 2.85 to 3.61), moderate 1.41 (95% CI: 1.24 to 1.59) and slight 0.24 (95% CI 0.06 to 0.42). When the results were weighted to match the distribution of severity in the RCT, the ICIQ-UI SF score reduction was 2.2 compared with 3.9 in the RCT. Regarding PGI-I, 65% experienced improvement compared with 92% in the RCT. CONCLUSIONS: The app Tät was effective for self-management of UI even in the real world. Although the reduction in incontinence symptoms was less than in the RCT, two-thirds of the users improved. App-based treatment reaches many women without requiring resources from ordinary healthcare services. |
format | Online Article Text |
id | pubmed-7783523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-77835232021-01-11 Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study Rygh, Pontus Asklund, Ina Samuelsson, Eva BMJ Open Urology OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the RCT. DESIGN: Prospective cohort study. PARTICIPANTS: During a 17-month period, 24 602 non-pregnant, non-postpartum women older than 18 years downloaded the app and responded anonymously to a questionnaire. Of these, 2672 (11%) responded to the 3-month follow-up. INTERVENTION: Three months’ use of the app Tät, containing information, a pelvic floor muscle training programme and lifestyle advice. MAIN OUTCOME MEASURES: Change in symptom severity (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)) and subjective improvement (Patient Global Impression of Improvement (PGI-I)). RESULTS: Of the respondents, 88% lived in Sweden and 75% (18 384/24 602) were incontinent with a mean age of 45.5 (SD 14.1) years. The UI types, based on symptoms, were SUI (53%), urgency UI (12%), mixed UI (31%) and undefined (4%). The mean ICIQ-UI SF score was 8.2 (SD 4.0) at baseline. The mean ICIQ-UI SF score reduction at follow-up was 1.31 (95% CI: 1.19 to 1.44) with a larger reduction in those with more severe incontinence at baseline (severe/very severe 3.23 (95% CI: 2.85 to 3.61), moderate 1.41 (95% CI: 1.24 to 1.59) and slight 0.24 (95% CI 0.06 to 0.42). When the results were weighted to match the distribution of severity in the RCT, the ICIQ-UI SF score reduction was 2.2 compared with 3.9 in the RCT. Regarding PGI-I, 65% experienced improvement compared with 92% in the RCT. CONCLUSIONS: The app Tät was effective for self-management of UI even in the real world. Although the reduction in incontinence symptoms was less than in the RCT, two-thirds of the users improved. App-based treatment reaches many women without requiring resources from ordinary healthcare services. BMJ Publishing Group 2021-01-04 /pmc/articles/PMC7783523/ /pubmed/33397664 http://dx.doi.org/10.1136/bmjopen-2020-040819 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Urology Rygh, Pontus Asklund, Ina Samuelsson, Eva Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title | Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title_full | Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title_fullStr | Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title_full_unstemmed | Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title_short | Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
title_sort | real-world effectiveness of app-based treatment for urinary incontinence: a cohort study |
topic | Urology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783523/ https://www.ncbi.nlm.nih.gov/pubmed/33397664 http://dx.doi.org/10.1136/bmjopen-2020-040819 |
work_keys_str_mv | AT ryghpontus realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy AT asklundina realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy AT samuelssoneva realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy |